Name | 2-[2-[4,5-bis(4-methoxyphenyl)-1,3-thiazol-2-yl]pyrrol-1-yl]acetic acid |
---|---|
Synonyms |
1H-Pyrrole-1-aceticacid,2-[4,5-bis(4-methoxyphenyl)-2-thiazolyl]
Desethyl KB 3022 2-(4,5-Bis(4-methoxylphenyl)thiazol-2-yl)pyrrol-1-ylacetic acid Desethyl kbt-3022 |
Description | Desethyl KBT-3022 is the main active metabolite of the new antiplatelet agent, KBT-3022. |
---|---|
Related Catalog | |
In Vitro | Pretreatment with desethyl KBT-3022 0.1, 0.3 and 1 mg/kg, i.v. prolongs the time required to achieve thrombotic occlusion in the femoral artery and inhibits collagen-induced platelet aggregation in whole blood ex vivo, each in a dose-dependent manner. Desethyl KBT-3022 inhibits the thrombin-induced aggregation of washed platelets in a concentration-dependent manner 1–40 μM[1]. |
References |
Density | 1.29g/cm3 |
---|---|
Boiling Point | 630.3ºC at 760mmHg |
Molecular Formula | C23H20N2O4S |
Molecular Weight | 420.48100 |
Flash Point | 335ºC |
Exact Mass | 420.11400 |
PSA | 101.82000 |
LogP | 5.04740 |
Vapour Pressure | 9.4E-17mmHg at 25°C |
Index of Refraction | 1.642 |